ORKA
Oruka Therapeutics, Inc.
84.50$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -53.8% | +58.3% | +26.3% | +12.5% | -18.5% | +304.5% | +4.5% | -2.2% | +25.3% | -76.3% | +207.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -133.0% | – | +284.6% | -78.8% | -815.3% | – | +325.6% | -101.5% | – | – | -122.0% | |
| – | -40.6% | -42.1% | +9.1% | -75.0% | +33.3% | +0.0% | +375.0% | +126.3% | -95.3% | +9,350.0% | +10.6% | |
| – | -40.6% | -42.1% | +149,118.2% | – | -76.4% | -100.1% | +375.0% | +126.3% | -95.3% | +16,506,250.0% | -70.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -58.1% | +323.7% | – | – | -46.9% | +111.3% | +638.6% | -52.3% | – | – | -62.1% | |
| – | -110.1% | – | -233.9% | – | -261.0% | – | +2,219.5% | -89.5% | -354.5% | – | -160.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.